Next Article in Journal
Liver Enhancement on Computed Tomography Is Suboptimal in Patients with Liver Steatosis
Previous Article in Journal
Nature of Acquired Immune Responses, Epitope Specificity and Resultant Protection from SARS-CoV-2
Article

Identification of a Rare Novel KMT2C Mutation That Presents with Schizophrenia in a Multiplex Family

1
Department of Psychiatry, Chang Gung Memorial Hospital-Linkou, Taoyuan 333, Taiwan
2
Department and Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan
3
Department of Psychiatry, Yuli Branch, Taipei Veterans General Hospital, Hualien 981, Taiwan
*
Author to whom correspondence should be addressed.
Academic Editor: Piotr Galecki
J. Pers. Med. 2021, 11(12), 1254; https://doi.org/10.3390/jpm11121254 (registering DOI)
Received: 23 October 2021 / Revised: 19 November 2021 / Accepted: 24 November 2021 / Published: 25 November 2021
Schizophrenia is a complex genetic disorder involving many common variants with modest effects and rare mutations with high penetrance. Rare mutations associated with schizophrenia are highly heterogeneous and private for affected individuals and families. Identifying such mutations can help establish the molecular diagnosis, elucidate the pathogenesis, and provide helpful genetic counseling for affected patients and families. We performed a whole-exome sequencing analysis to search for rare pathogenic mutations co-segregating with schizophrenia transmitted in a dominant inheritance in a two-generation multiplex family. We identified a rare missense mutation H1574R (Histidine1574Arginine, rs199796552) of KMT2C (lysine methyltransferase 2C) co-segregating with affected members in this family. The mutation is a novel deleterious mutation of KMT2C, not reported before in the literature. The KMT2C encodes a histone 3 lysine 4 (H3K4)-specific methyltransferase and involves epigenetic regulation of brain gene expression. Mutations of KMT2C have been found in neurodevelopmental disorders, such as Kleefstra syndrome, intellectual disability, and autism spectrum disorders. Our finding suggests that schizophrenia might be one of the clinical phenotype spectra of KMT2C mutations, and KMT2C might be a novel risk gene for schizophrenia. Nevertheless, the co-segregation of this mutation with schizophrenia in this family might also be due to chance; functional assays of this mutation are needed to address this issue. View Full-Text
Keywords: schizophrenia; whole-genome sequencing; rare mutation; KMT2C; histone 3 lysine 4; methylation schizophrenia; whole-genome sequencing; rare mutation; KMT2C; histone 3 lysine 4; methylation
Show Figures

Figure 1

MDPI and ACS Style

Chen, C.-H.; Huang, A.; Huang, Y.-S.; Fang, T.-H. Identification of a Rare Novel KMT2C Mutation That Presents with Schizophrenia in a Multiplex Family. J. Pers. Med. 2021, 11, 1254. https://doi.org/10.3390/jpm11121254

AMA Style

Chen C-H, Huang A, Huang Y-S, Fang T-H. Identification of a Rare Novel KMT2C Mutation That Presents with Schizophrenia in a Multiplex Family. Journal of Personalized Medicine. 2021; 11(12):1254. https://doi.org/10.3390/jpm11121254

Chicago/Turabian Style

Chen, Chia-Hsiang, Ailing Huang, Yu-Shu Huang, and Ting-Hsuan Fang. 2021. "Identification of a Rare Novel KMT2C Mutation That Presents with Schizophrenia in a Multiplex Family" Journal of Personalized Medicine 11, no. 12: 1254. https://doi.org/10.3390/jpm11121254

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop